Actively Recruiting

Phase 3
Age: 18Years - 35Years
FEMALE
Healthy Volunteers
ID06858111

Phase III Randomized Control Trial to Investigate the Safety and Efficacy of Fertilo Versus Medicult In Vitro Maturation (IVM)

Led by Gameto, Inc. · Updated on 2026-06-04

500

Participants Needed

13

Research Sites

35 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the safety and effectiveness of Fertilo compared to Medicult IVM for in vitro maturation (IVM) of eggs in women aged 18 to 35. The study aims to determine if Fertilo leads to more ongoing pregnancies at 12 weeks gestation than the currently approved Medicult IVM system. This is a phase III randomized control trial sponsored by Gameto, Inc.

CONDITIONS

Brief Title

Fertilo In Vitro Research Study and Trial

Who Can Participate

Age: 18Years - 35Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Written informed consent is required.
  • Female participants aged 18 to 35 years who are premenopausal.
  • Body mass index (BMI) between 21 and 40.
  • Must be a candidate for IVF as defined by infertility for 12 months or more, need for donor sperm, or difficulty achieving pregnancy based on medical history.
  • No contraindications to the use of oral contraceptive pills or gonadotropins.
  • Embryo use planned within 2 months after blastocyst freezing.
  • Anti-mullerian hormone (AMH) level of 3 ng/mL or higher within 6 months before screening or assessed at screening.
  • Normal uterine cavity confirmed by hysteroscopy, hysterosalpingography, or sonohysterography within 12 months before screening or assessed at screening.
  • Adequate visualization of both ovaries without major abnormalities or cysts confirmed by transvaginal ultrasound within 3 months before screening or assessed during screening.
  • No severe endometriosis (American Fertility Society grade 3 or 4) or presence of endometrioma.
  • At least 1 month without treatment using clomiphene citrate, GnRH agonist, or gonadotropins before ovarian stimulation starts.
  • Male partner must have a semen analysis within 12 months before randomization suitable for intracytoplasmic sperm injection (ICSI), or donor sperm will be used.
Not Eligible

You will not qualify if you...

  • History of recurrent pregnancy loss defined as more than 2 clinical pregnancies without a live birth.
  • Baseline prolactin levels above 30 ng/ml.
  • Male partner requiring retrograde ejaculation procedures or surgical sperm retrieval.
  • Any medical condition judged to impair embryo implantation or continuation of pregnancy.
  • Use of preimplantation genetic testing (PGT) during the study.
  • Use of donated oocytes, embryos, or blastocysts for the current treatment cycle or from previous cycles.
  • Participation in another clinical trial or investigational drug trial within the past 2 months.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 screening and enrollment visit

Treatment

Duration - Up to 2 months after blastocyst freezing

Participants undergo in vitro maturation of immature oocytes using either Fertilo or MediCult IVM®, followed by fertilization, embryo growth to blastocyst stage, vitrification, and later embryo transfer for reproductive purposes.

Visits occur for oocyte retrieval, fertilization, embryo culture, and embryo transfer procedures

Follow-up

Duration - Up to greater than 24 weeks gestation

Participants are followed to monitor pregnancy outcomes including biochemical pregnancy, clinical pregnancy, and live birth.

Approximately 3 visits including follow-up at 10 to 14 days, 4 to 6 weeks, and after 24 weeks of gestation

Trial Site Locations

Total: 13 locations

1

Women's Specialty & Fertility Center

Clovis, California, United States, 93611

Actively Recruiting

2

HRC Fertility

Encino, California, United States, 91436

Actively Recruiting

3

Florida Fertility Institute

Clearwater, Florida, United States, 33759

Actively Recruiting

4

IVF Florida

Pembroke Pines, Florida, United States, 33026

Actively Recruiting

5

Shady Grove Fertility

Rockville, Maryland, United States, 20850

Actively Recruiting

6

Columbia University Fertility Center

New York, New York, United States, 10019

Actively Recruiting

7

Reach Fertility

Charlotte, North Carolina, United States, 28207

Actively Recruiting

8

Conceptions Fertility

Raleigh, North Carolina, United States, 27607

Actively Recruiting

9

Care Fertility

Bedford, Texas, United States, 76022

Actively Recruiting

10

Dallas Fort Worth Fertility Associates

Dallas, Texas, United States, 75231

Actively Recruiting

11

Aspire Fertility San Antonio

San Antonio, Texas, United States, 78528

Actively Recruiting

12

Shady Grove Houston

Webster, Texas, United States, 77598

Actively Recruiting

13

Utah Fertility Center

Pleasant Grove, Utah, United States, 84062

Actively Recruiting

Loading map...

Research Team

C

Clinical Trials

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Similar Trials

Effectiveness and Safety of In Vitro Maturation With Fresh E...

Polycystic Ovary Syndrome (PCOS)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here